ROCK1 and cancer: Since PMOP patients had a higher risk to get some types of cancer, we were greatly interested in whether the low expression of ROCK1 made great importance to increasing the cancer risk, accelerating the cancer progression, or worsening the cancer prognosis [29, 30].